Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Feb;79(2):566–571. doi: 10.1172/JCI112848

Monocyte-T lymphocyte interaction for regulation of insulin receptors of the activated T lymphocyte.

J H Helderman, R Ayuso, J Rosenstock, P Raskin
PMCID: PMC424128  PMID: 3543055

Abstract

During activation the lymphocyte attains functional insulin receptors with precise regulation, a consequence of insulin concentration manipulations. These studies test the hypothesis that insulin receptor (+) monocytes monitor insulin concentrations, so instructing the T lymphocytes. Monocyte-enriched populations were incubated with insulin (0-10(-6) M) followed by co-culture with T lymphocytes and an activating stimulus. A dose-related fall in T lymphocyte insulin receptor binding was observed that was specific for the monocyte as the signalling cell and for insulin as the signal received. Monocytes from normal volunteers during a euglycemic, hyperinsulinemic clamp were cultured with T lymphocytes and an activating stimulus. A decline in specific insulin receptor binding on T lymphocytes was observed, which Scatchard analysis demonstrated to be a consequence of reduction in receptor numbers. These studies demonstrate that the receptor (+) monocyte perceives the concentration of insulin and passes this information to T lymphocytes regulating the number of activation-induced insulin receptors. The interplay between the monocyte and T lymphocyte parallels the interaction of these cell types for recognition of antigen.

Full text

PDF
566

Images in this article

567Image
on p.567
570Image
on p.570
570Image
on p.570

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar R. S., Stueck S., Dake B., Spanheimer R. Multiplication-stimulating activity (MSA) stimulates proteoglycan synthesis in cultured endothelial cells. Endocrinology. 1984 Dec;115(6):2487–2489. doi: 10.1210/endo-115-6-2487. [DOI] [PubMed] [Google Scholar]
  2. Braciale V. L., Gavin J. R., 3rd, Braciale T. J. Inducible expression of insulin receptors on T lymphocyte clones. J Exp Med. 1982 Aug 1;156(2):664–669. doi: 10.1084/jem.156.2.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  4. Ercolani L., Brown T. J., Ginsberg B. H. Tunicamycin blocks the emergence and maintenance of insulin receptors on mitogen-activated human T lymphocytes. Metabolism. 1984 Apr;33(4):309–316. doi: 10.1016/0026-0495(84)90189-6. [DOI] [PubMed] [Google Scholar]
  5. Ercolani L., Parsons T. J., Hoak J. C., Fry G. L., Nghiem D. D. Induction and amplification of T-lymphocyte proliferative responses to periodate and soybean agglutinin by human adult vascular endothelial cells. Cell Immunol. 1984 Apr 15;85(1):225–234. doi: 10.1016/0008-8749(84)90292-2. [DOI] [PubMed] [Google Scholar]
  6. Galbraith R. M., Galbraith G. M. Expression of transferrin receptors on mitogen-stimulated human peripheral blood lymphocytes: relation to cellular activation and related metabolic events. Immunology. 1981 Dec;44(4):703–710. [PMC free article] [PubMed] [Google Scholar]
  7. Galbraith R. M., Werner P., Arnaud P., Galbraith G. M. Transferrin binding to peripheral blood lymphocytes activated by phytohemagglutinin involves a specific receptor. Ligand interaction. J Clin Invest. 1980 Nov;66(5):1135–1143. doi: 10.1172/JCI109943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Helderman J. H. Acute regulation of human lymphocyte insulin receptors. Analysis by the glucose clamp. J Clin Invest. 1984 Oct;74(4):1428–1435. doi: 10.1172/JCI111554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Helderman J. H., Elahi D., Andersen D. K., Raizes G. S., Tobin J. D., Shocken D., Andres R. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes. 1983 Feb;32(2):106–111. doi: 10.2337/diab.32.2.106. [DOI] [PubMed] [Google Scholar]
  10. Helderman J. H., Gruchalla R., Edwards L. E. Effect of insulin and transferrin in the maintenance of the activated state of the T-lymphocyte induced by allo-antigen. Diabetologia. 1984 Jul;27 (Suppl):99–101. doi: 10.1007/BF00275659. [DOI] [PubMed] [Google Scholar]
  11. Helderman J. H., Pietri A. O., Raskin P. In vitro control of T-lymphocyte insulin receptors by in vivo modulation of insulin. Diabetes. 1983 Aug;32(8):712–717. doi: 10.2337/diab.32.8.712. [DOI] [PubMed] [Google Scholar]
  12. Helderman J. H., Reynolds T. C., Strom T. B. The insulin receptor as a universal marker of activated lymphocytes. Eur J Immunol. 1978 Aug;8(8):589–595. doi: 10.1002/eji.1830080810. [DOI] [PubMed] [Google Scholar]
  13. Helderman J. H. Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. J Clin Invest. 1981 Jun;67(6):1636–1642. doi: 10.1172/JCI110199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Helderman J. H., Strom T. B. Emergence of insulin receptors upon alloimmune T cells in the rat. J Clin Invest. 1977 Feb;59(2):338–344. doi: 10.1172/JCI108646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Helderman J. H., Strom T. B. Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes. J Biol Chem. 1979 Aug 10;254(15):7203–7207. [PubMed] [Google Scholar]
  16. Helderman J. H., Strom T. B. Specific insulin binding site on T and B lymphocytes as a marker of cell activation. Nature. 1978 Jul 6;274(5666):62–63. doi: 10.1038/274062a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Helderman J. H., Strom T. B. The insulin receptor: a marker of T cell activation after allograft. Proc Clin Dial Transplant Forum. 1976 Nov 19;6:154–158. [PubMed] [Google Scholar]
  18. Helderman J. H. T cell cooperation for the genesis of B cell insulin receptors. J Immunol. 1983 Aug;131(2):644–650. [PubMed] [Google Scholar]
  19. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  20. Kumagai J., Akiyama H., Iwashita S., Iida H., Yahara I. In vitro regeneration of resting lymphocytes from stimulated lymphocytes and its inhibition by insulin. J Immunol. 1981 Apr;126(4):1249–1254. [PubMed] [Google Scholar]
  21. McGuire E. A., Helderman J. H., Tobin J. D., Andres R., Berman M. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol. 1976 Oct;41(4):565–573. doi: 10.1152/jappl.1976.41.4.565. [DOI] [PubMed] [Google Scholar]
  22. Robb R. J., Munck A., Smith K. A. T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med. 1981 Nov 1;154(5):1455–1474. doi: 10.1084/jem.154.5.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES